Arcadia to price IPO of 7.15 million shares between $13.00 and $15.00

Bookrunners Credit Suisse, JPMorgan, Piper Jaffray assist with sale

By Devika Patel

Knoxville, Tenn., May 11 – Arcadia Biosciences, Inc. will sell 7.15 million common shares in its initial public offering with a greenshoe option of 1,072,500 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced on Feb. 17.

The shares will be sold at a price expected to fall between $13.00 and $15.00 per share.

Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Piper Jaffray & Co. are the bookrunning managers.

Proceeds will be used for general corporate purposes, including working capital, capital expenditures, development and commercialization and sales and marketing.

The agricultural biotechnology trait development company is based in Davis, Calif. The company intends to list its common stock on the Nasdaq under the symbol “RKDA.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.